Skip to main content
. 2021 May 4;99(7):680–696. doi: 10.1111/imcb.12456

Figure 1.

Figure 1

Comparison of analysis methods for low‐ and high‐dimensional cytometry data sets. (a) A typical analysis pathway with low‐dimensional cytometry performed in 2013. (b) A new analysis pathway with high‐dimensional cytometry, using the same type of samples as in a, performed in 2020. IFN, interferon; IL, interleukin; TNF, tumor necrosis factor.